Thomas Plitz
Director/Board Member at RELIEF THERAPEUTICS HOLDING SA
Net worth: 1 804 $ as of 2024-03-30
Profile
Thomas Plitz is currently the Chief Executive Officer at Chord Therapeutics SA and the Vice Chairman at RELIEF THERAPEUTICS Holding SA. Previously, he held positions as Principal at Shire Pharmaceuticals, Inc., Serono Corp., and Merck Serono Ltd.
He also served as the Chief Scientific Officer at Wilson Therapeutics AB.
Dr. Plitz obtained a doctorate degree from Technische Universität München.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-29 | 1,250 ( 0.01% ) | 1 804 $ | 2024-03-30 |
Thomas Plitz active positions
| Companies | Position | Start |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Director/Board Member | 2020-12-16 |
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Chief Executive Officer | 2020-07-31 |
Former positions of Thomas Plitz
| Companies | Position | End |
|---|---|---|
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | - |
| Serono Corp. | Corporate Officer/Principal | - |
| WILSON THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Plitz
| Technische Universität München | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| Serono Corp. | |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
| RELIEF THERAPEUTICS Holding SA | |
Chord Therapeutics SA
Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Thomas Plitz
